
|Articles|May 24, 2019
ICON Acquires MeDiNova Research in Europe and Africa
Advertisement
ICON plc has announced that it has acquired a majority shareholding in MeDiNova Research, a site network with research sites in Europe and Africa, and that it has the right to acquire the remaining shares in the company by Quarter Three 2020. MeDiNova Research currently has a network of 33 active clinical research sites in the UK, Spain, South Africa, Poland and Romania.
For more information click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Business Case for DEI in Pharmaceutical Innovation: Why Organizational Commitment Matters for Inclusive Clinical Trials
2
Why Startup Timelines Are Worsening—and How to Reverse the Trend
3
ACT Brief: Signal Durability Redefines RBQM, AI Targets Startup Friction, and CDMOs Advance Patient-Centric Formulation
4
The Evolution of Global Trial Strategies in Today's Complex Healthcare Landscape
5




